Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference Transcript
05:22pm, Wednesday, 03'rd Jun 2026
Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor
08:00am, Wednesday, 03'rd Jun 2026
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in [url="]tubeless insulin pump technology[/url] with its Omnipod brand of pro
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor
07:00am, Wednesday, 03'rd Jun 2026
ACTON, Mass.--(BUSINESS WIRE)--Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus Sensor.
Insulet (PODD) is a Top-Ranked Growth Stock: Should You Buy?
10:46am, Tuesday, 02'nd Jun 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
PODD Stock: What a Hold Rating Says at a $163 Target
10:56am, Thursday, 28'th May 2026
Insulet earns a short-term Hold as outlook rises; a $163 sales-based target tests whether growth can beat 2026 volatility.
US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlow
10:34am, Thursday, 28'th May 2026
A U.S. appeals court on Thursday overturned a $452 million verdict that medical device maker Insulet won against Korean rival EOFlow for allegedly stealing trade secrets related to i
Insulet to Participate in William Blair 46th Annual Growth Stock Conference
04:05pm, Wednesday, 27'th May 2026
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will pres
PODD and Omnipod 5: What's Driving Insulet's 2026 Growth
12:05pm, Wednesday, 27'th May 2026
Insulet's Omnipod 5 drives a Q1 beat and raised 2026 outlook as upgrades and global rollout expand access - while correction costs loom.
Stock Futures Higher as Micron Stock Extends Rally
09:05am, Wednesday, 27'th May 2026
Stock futures are firmly higher as Micron Technology (MU) stock extends its rally
Insulet flags dosing defect in some Omnipod devices, sees up to $50 million cost
04:50pm, Tuesday, 26'th May 2026
Insulet said on Tuesday it is carrying out a voluntary correction of certain insulin pump pods across its Omnipod product lines after identifying a manufacturing issue that could result in patie
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets
04:05pm, Tuesday, 26'th May 2026
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation, Inc. (NASDAQ: PODD) (“Insulet” or the “Company”) today announced a voluntary Medical Device Correction for specific lots of Omnipod® 5, Omn
Insulet Corp (PODD) Shares Surge 3.5% -- What GF Score of 82 Tells Investors
08:15pm, Monday, 18'th May 2026
On May 18, 2026, Insulet Corp (PODD) shares rose 3.5% to a current price of $152.49. Over the past 52 weeks, the stock has fluctuated between a high of $354.88
Insulet Corporation (PODD) Presents at Bank of America Global Healthcare Conference 2026 Transcript
02:50pm, Wednesday, 13'th May 2026
Insulet Corporation (PODD) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Insulet: An Opportune Time To Get Involved
11:04am, Wednesday, 13'th May 2026
Insulet delivered robust Q1 2026 results, with revenue up 34% to $762M and operating margins expanding to 17.5%. Insulet raised full-year guidance to 21-23% sales growth and expects adjusted earnings
Here's Why Insulet (PODD) is a Strong Growth Stock
10:46am, Tuesday, 12'th May 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
